Overview

Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Summary
To assess the long-term safety and tolerability of tiagabine treatment in patients with generalized anxiety disorder (GAD).
Phase:
Phase 3
Details
Lead Sponsor:
Cephalon
Treatments:
Tiagabine